XML 126 R111.htm IDEA: XBRL DOCUMENT v3.25.1
Note 23 - Fair Value of Financial Instruments (Details Textual)
$ in Thousands
3 Months Ended 10 Months Ended 12 Months Ended 24 Months Ended
Dec. 31, 2024
USD ($)
Oct. 31, 2024
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2022
Payment for Contingent Consideration Liability, Financing Activities     $ 650 $ 375      
Private Company Investments [Member]              
Equity Method Investment, Other-than-Temporary Impairment     0 100      
Ravix [Member]              
Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High   $ 4,500          
Payment for Contingent Consideration Liability, Financing Activities $ 700       $ 1,100    
Business Combination, Contingent Consideration, Liability $ 2,700   $ 2,700 3,100 3,100 $ 3,400  
Business Combination, Contingent Consideration, Liability, Interest Rate 6.00%   6.00%        
Ravix [Member] | Maximum [Member]              
Business Combination, Contingent Consideration, Accrued Interest $ 100   $ 100        
CSuite Acquisition, LLC [Member]              
Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High     3,600        
Business Combination, Contingent Consideration, Liability $ 0   $ 0 $ 0 $ 0    
Trust Preferred Debt Repurchase Options Contracts [Member]              
Derivative, Number of Instruments Held, Total             3